Skip to content
Topics/Renal & Genitourinary

Acute kidney injury

Pro
Audio podcast
Listen on the go — with live captions.
Infographic
High-yield one-pager.
Slide deck
Tight, illustrated review.
MCQs
10 questions available
Easy · 1
Medium · 6
Hard · 3

Case simulations

Learn this topic by working through ED cases step-by-step.

medium
~15 min
Pro
72M with severe dehydration and oliguria

A 72-year-old male presents with profound weakness, dizziness, and decreased urine output after 3 days of severe diarrhea.

hard
~15 min
Pro
45F lung transplant recipient with oliguria

A 45-year-old female, 3 months post-bilateral lung transplant, presents with a dramatic rise in creatinine and oliguria.

Mind map

Summary

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

Acute kidney injury (AKI) is an abrupt reduction in the glomerular filtration rate (GFR), resulting in the failure to maintain fluid homeostasis and clear metabolic waste. The underlying pathophysiology is functionally divided into three categories:

  • Prerenal (Perfusion Failure): Driven by severe intravascular volume depletion (hemorrhage, dehydration) or decreased effective arterial volume (heart failure, sepsis). The kidneys are structurally intact but hypoperfused.
  • Intrinsic (Cellular Injury): Direct damage to the renal parenchyma. This is most commonly Acute Tubular Necrosis (ATN) resulting from prolonged untreated prerenal ischemia, or from direct nephrotoxins (e.g., aminoglycosides, radiocontrast, calcineurin inhibitors like tacrolimus). It can also involve the glomerulus (glomerulonephritis) or interstitium (acute interstitial nephritis).
  • Postrenal (Mechanical Obstruction): Physical obstruction of the urinary outflow tract (e.g., prostatic hypertrophy, bilateral calculi, pelvic malignancy) increasing retrograde hydrostatic pressure within Bowman's capsule, ultimately halting glomerular filtration.

As GFR plummets, the kidneys fail to secrete potassium (causing lethal hyperkalemia), fail to excrete metabolic acids (causing high anion gap metabolic acidosis), and fail to excrete phosphate. The resulting hyperphosphatemia precipitates with serum calcium, driving a dangerous secondary hypocalcemia.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

  • Immediate Stabilization: Assess ABCs, establish large-bore IV access, and immediately place the patient on a continuous cardiac monitor to evaluate for hyperkalemic dysrhythmias. Place a Foley catheter early; it accurately measures strict urine output and acts as a direct therapeutic intervention if lower-tract obstruction is present.
  • Targeted Volume Resuscitation:
  • Prerenal/Hypovolemic: Administer an initial IV fluid challenge of 20 mL/kg of isotonic crystalloids (e.g., 0.9% NaCl or Lactated Ringer's). Reassess the clinical response rapidly to avoid tipping the patient into volume overload.
  • Euvolemic/Hypervolemic: Strictly avoid fluid boluses.
  • Pharmacotherapy Pearls & Pitfalls:
  • Diuretic Resistance: In cardiorenal syndrome presenting with volume overload and loop-diuretic resistance, initiate sequential nephron blockade by adding a thiazide-like diuretic (e.g., metolazone) to the IV loop diuretic.
  • Discontinue Nephrotoxins: Immediately stop ACE inhibitors, ARBs, NSAIDs, and nephrotoxic antibiotics. Adjust all ED medication doses for renal impairment.
  • Debunked Therapies: Do not use mannitol or low-dose ("renal") dopamine; they do not improve renal recovery or decrease mortality.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

  • "Can't-Miss" Differential Diagnoses:
  • Hemolytic Uremic Syndrome (HUS) / TTP: Suspect in patients presenting with AKI, thrombocytopenia, and microangiopathic hemolytic anemia.
  • Rhabdomyolysis: Massive myoglobin release causing intrinsic tubular toxicity; suspect if creatine kinase (CK) > 10,000 IU/L.
  • Cardiorenal Syndrome: Acute decompensated heart failure driving functional renal decline.
  • Prioritized Diagnostic Workup:
  • Point-of-Care VBG/BMP: Assess immediately for hyperkalemia, severe metabolic acidosis, BUN/Creatinine levels, and secondary hypocalcemia.
  • Urinalysis & Indices: Essential to differentiate etiology. Muddy brown granular casts suggest ATN; red cell casts suggest glomerulonephritis; white cell casts suggest interstitial nephritis or infection. A fractional excretion of sodium (FENa) < 1% or a Urine:Plasma osmolality ratio > 5 strongly suggests prerenal etiology.
  • Specific Drug Levels: Check a tacrolimus level in any solid organ transplant recipient presenting with AKI.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

  • 12-Lead ECG: The most critical initial diagnostic test. Actively scrutinize for signs of hyperkalemia: peaked T-waves, flattened P-waves, prolonged PR intervals, widened QRS complexes, or a sine-wave morphology.
  • Point-of-Care Ultrasound (POCUS - IVC): Differentiate the shock/hypoperfusion state. A fully collapsible, flat inferior vena cava (IVC) suggests profound hypovolemia (prerenal). A dilated, plethoric IVC with minimal respiratory variation suggests volume overload, right heart failure, or cardiorenal syndrome.
  • POCUS - Renal/Bladder: Assess the kidneys for hydronephrosis to rapidly rule in or rule out postrenal obstruction. Evaluate the bladder for urinary retention. Note that small, shrunken kidneys suggest underlying Chronic Kidney Disease (CKD) rather than an isolated AKI.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

  • KDIGO Diagnostic Criteria for AKI: The diagnosis is confirmed if any of the following are met:
  1. Absolute increase in serum creatinine $\ge$ 0.3 mg/dL (or $\ge$ 26 $\mu$mol/L) within 48 hours.
  2. Increase in serum creatinine $\ge$ 1.5 times baseline within 7 days.
  3. Urine output $\le$ 0.5 mL/kg/hr for 6 hours.
  • KDIGO Stage 3 (Severe AKI): Defined by a creatinine > 3 times baseline (or $\ge$ 2.5 mg/dL to 4.0 mg/dL depending on age/criteria), anuria for $\ge$ 12 hours, or the initiation of renal replacement therapy.
  • The Furosemide Stress Test: Used to predict progression to Stage 3 AKI. Administer 1 mg/kg IV furosemide to a diuretic-naive patient. A urine output of < 200 mL over the subsequent 2 hours indicates a high risk of progression and poor renal recovery.
  • Indications for Emergent Dialysis (AEIOU):
  • Acidosis (severe, refractory metabolic acidosis).
  • Electrolytes (refractory hyperkalemia > 6.5 mmol/L).
  • Intoxications (dialyzable toxins: salicylates, lithium, toxic alcohols).
  • Overload (refractory volume overload/pulmonary edema).
  • Uremia (uremic pericarditis or progressive encephalopathy).

6. THE DANGER ZONE (Pitfalls & Critical Actions)

  • Cognitive Trap (The Blind Fluid Bolus): Reflexively administering large fluid boluses to all oliguric patients. Correction: Patients with AKI can present with systemic fluid overload despite poor urine output. Administering fluids to a hypervolemic or cardiorenal patient can precipitate fatal pulmonary edema. Use POCUS to guide volume resuscitation.
  • Cognitive Trap (Waiting for the Lab): Delaying hyperkalemia treatment while waiting for the formal comprehensive metabolic panel to result. Correction: If the ECG demonstrates classical hyperkalemic changes in the setting of known renal failure, administer membrane stabilization (calcium gluconate/chloride) immediately.
  • Critical Action: Differentiate between acute anuria (<100 mL/day) and oliguria. Acute, complete anuria is highly indicative of complete urinary tract obstruction, bilateral renal vascular occlusion, or severe cortical necrosis, mandating immediate mechanical evaluation (POCUS/catheter).

7. MCQ MASTERCLASS (Written Exam Tips)

  • Buzzwords: "Muddy brown granular casts" (Acute Tubular Necrosis), "Red blood cell casts" (Glomerulonephritis), "Hyaline casts" (Pre-renal/Dehydration), "Urine Na < 20 mEq/L and FENa < 1%" (Pre-renal).
  • Classic Distractor (The Dialysis Trap): A patient presents with AKI and an intentional amlodipine overdose. The distractor option will suggest "Emergent hemodialysis for intoxication." Explanation: Amlodipine is highly protein-bound and cannot be dialyzed. The "I" in the AEIOU criteria refers strictly to dialyzable toxins like salicylates, lithium, and toxic alcohols.
  • Classic Distractor (The Medication Rescue): A clinical vignette describes an oliguric AKI patient in the ICU. The question asks for the best medication to promote renal recovery. Distractor options will include mannitol or renal-dose dopamine. Explanation: Neither mannitol nor low-dose dopamine prevents progression or improves mortality in AKI. Choose volume optimization or definitive renal replacement therapy.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

  • The Initial Approach: "This patient is presenting with acute oliguria and a rising creatinine, meeting KDIGO criteria for acute kidney injury. I will immediately assess their ABCs, place them on a continuous cardiac monitor to evaluate for hyperkalemic dysrhythmias, and order a stat ECG and point-of-care VBG/BMP."
  • Executing the Diagnostic Resuscitation: "I am utilizing point-of-care ultrasound to evaluate the IVC, heart, and kidneys. Because the IVC is flat and fully collapsible, this points to a prerenal hypovolemic etiology; I will administer an initial 20 mL/kg fluid challenge with isotonic crystalloid. Had I seen bilateral hydronephrosis or a distended bladder, I would have immediately placed a Foley catheter to relieve postrenal obstruction."
  • Definitive Care Hand-off: "I am reviewing the patient's medication list to discontinue all nephrotoxic agents, specifically their ACE inhibitor and NSAIDs. The patient currently does not meet the AEIOU criteria for emergent hemodialysis. I will place a Foley catheter for strict input and output monitoring, calculate their fractional excretion of sodium, and consult nephrology for admission."